VERDICT APPROVE

No findings.

- **Identity verified.** `ja1/s3` remains at `4250d146eb767b64a058bcbafb5f9adbccbb5264`. All 49 live hashes match the final manifest. Exactly 48 match round three; only C11 differs, exactly as recorded in the delta. No additional source changes were found.
- **Ownership is correct.** [ja_s2_c11.rs:105](/home/riels/.t3/worktrees/Kinewright/t3-1c0887c5/crates/kinewright-agent/tests/support/ja_s2_c11.rs:105) admits a clone and retains the original owned entry before FirstSave and host transfer. Its nested fields contain no shared mutable aliases, handles, pins, or reservations. Later source/host changes cannot alter the expected value. Both other tuple callers safely discard this plain value without changing resource lifetimes.
- **Identity protection is strengthened.** [ja_s2_c11.rs:246](/home/riels/.t3/worktrees/Kinewright/t3-1c0887c5/crates/kinewright-agent/tests/support/ja_s2_c11.rs:246) compares every entry field, including canonical profile and dependencies. Cardinality and complete restart-attachment equality remain checked. Importer changes before capture can change the expected entry; this oracle tests preservation of imported facts through switching.
- **Prior placement error resolved.** Round one incorrectly treated pre-launch access as pre-transfer access. V2 removes that fenced-store read without weakening the barrier. The supplied [runtime log](/home/riels/.t3/worktrees/Kinewright/t3-1c0887c5/docs/reports/ja1-s3/evidence/regression-c11-switch.log.gz) records `test result: ok. 1 passed; 0 failed; 0 ignored`. The test executes both restore variants.

Checked the fixture delta, callers, ownership types, historical failure, current gate evidence, and hashes. No reviewer Cargo, tests, mutations, Clippy, or fmt execution. Wider campaigns were not re-audited; native Windows, full suites, and CI remain NOT RUN.

Prior unchanged-production conditional approvals remain applicable with this independently approved fixture delta. Their remaining evidence conditions still apply; deferred C1 findings remain deferred.
